Recombinant human interleukin 5 is a selective activator of human eosinophil function.

Angel F. López(South Australia Pathology), Colin J. Sanderson(South Australia Pathology), Jennifer R. Gamble(South Australia Pathology), HD Campbell(South Australia Pathology), IG Young(South Australia Pathology), M A Vadas(South Australia Pathology)
The Journal of Experimental Medicine
January 1, 1988
Cited by 958Open Access
Full Text

Abstract

Human rIL-5 was found to selectively stimulate morphological changes and the function of human eosinophils. This molecule is thus a prime candidate for the selective eosinophilia and eosinophil activation seen in disease.


Related Papers

No related papers found

Powered by citation graph analysis